{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:32:13Z","timestamp":1755217933149,"version":"3.43.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jacl.2025.07.002","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:05:26Z","timestamp":1752609926000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Major lipoprotein(a) increase under IGF-1R inhibition in Graves' orbitopathy: A case report"],"prefix":"10.1016","author":[{"given":"Maxime","family":"Carpentier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Olivier","family":"Bertho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3355-7715","authenticated-orcid":false,"given":"Pierre","family":"Lebranchu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Drui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1580-8040","authenticated-orcid":false,"given":"Bertrand","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"35","key":"10.1016\/j.jacl.2025.07.002_bib0001","doi-asserted-by":"crossref","first-page":"10424","DOI":"10.1021\/bi010556e","article-title":"The structure of lipoprotein(a) and ligand-induced conformational changes","volume":"40","author":"Weisel","year":"2001","journal-title":"Biochemistry"},{"issue":"10459","key":"10.1016\/j.jacl.2025.07.002_bib0002","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"404","author":"Nordestgaard","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jacl.2025.07.002_bib0003","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1016\/j.jacl.2024.03.001","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","volume":"18","author":"Koschinsky","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.jacl.2025.07.002_bib0004","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF00220066","article-title":"The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration","volume":"90","author":"Kraft","year":"1992","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacl.2025.07.002_bib0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2022.04.006","article-title":"Non-genetic influences on lipoprotein(a) concentrations","volume":"349","author":"Enkhmaa","year":"2022","journal-title":"Atherosclerosis"},{"issue":"39","key":"10.1016\/j.jacl.2025.07.002_bib0006","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2025.07.002_bib0007","article-title":"The effect of endocrine disorders on lipids and lipoproteins","author":"Feingold","year":"2023","journal-title":"In: Endotext"},{"issue":"12","key":"10.1016\/j.jacl.2025.07.002_bib0008","doi-asserted-by":"crossref","first-page":"dgaa672","DOI":"10.1210\/clinem\/dgaa672","article-title":"Treatment of thyroid dysfunction and serum lipids: a systematic review and meta-analysis","volume":"105","author":"Kotwal","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jacl.2025.07.002_bib0009","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0905633","article-title":"Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia","volume":"362","author":"Ladenson","year":"2010","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.jacl.2025.07.002_bib0010","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jacl.2025.07.002_bib0011","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1210\/jc.2016-1315","article-title":"TSH\/IGF-1 receptor cross talk in Graves\u2019 ophthalmopathy pathogenesis","volume":"101","author":"Krieger","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jacl.2025.07.002_bib0012","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.07.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ghir.2023.101548","article-title":"Administration of insulin like growth factor I (IGFI) lowers serum lipoprotein(a)-impact on atherosclerotic cardiovascular disease","volume":"71","author":"Laron","year":"2023","journal-title":"Growth Hormone IGF Res"},{"issue":"16","key":"10.1016\/j.jacl.2025.07.002_bib0014","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jacc.2023.02.033","article-title":"Clinical trial design for lipoprotein(a)-lowering therapies: JACC Focus Seminar 2\/3","volume":"81","author":"Malick","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacl.2025.07.002_bib0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/eje.0.1370459","article-title":"The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial","volume":"137","author":"Nolte","year":"1997","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.jacl.2025.07.002_bib0016","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11102-022-01207-1","article-title":"Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile","volume":"25","author":"Ratku","year":"2022","journal-title":"Pituitary"},{"issue":"7","key":"10.1016\/j.jacl.2025.07.002_bib0017","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ophtha.2024.01.023","article-title":"Glycemic trends in patients with thyroid eye disease treated with teprotumumab in 3 clinical trials","volume":"131","author":"Smith","year":"2024","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.jacl.2025.07.002_bib0018","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1158\/1078-0432.CCR-09-3220","article-title":"A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors","volume":"16","author":"Kurzrock","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jacl.2025.07.002_bib0019","doi-asserted-by":"crossref","first-page":"T187","DOI":"10.1530\/JME-18-0076","article-title":"Understanding the tissue-specific roles of IGF1\/IGF1R in regulating metabolism using the Cre\/LoxP system","volume":"61","author":"Kineman","year":"2018","journal-title":"J Mol Endocrinol"},{"issue":"6","key":"10.1016\/j.jacl.2025.07.002_bib0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2265.2009.03732.x","article-title":"The effect of in vivo growth hormone treatment on blood gene expression in adults with growth hormone deficiency reveals potential biomarkers to monitor growth hormone therapy","volume":"72","author":"Fern\u00e1ndez-P\u00e9rez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425003423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425003423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T23:43:29Z","timestamp":1754437409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425003423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":20,"alternative-id":["S1933287425003423"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.07.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"type":"print","value":"1933-2874"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Major lipoprotein(a) increase under IGF-1R inhibition in Graves' orbitopathy: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}